Page 75 - 86_01
P. 75
ANALES 73
RANF
www.analesranf.com
Protein 12. Sci Rep. 2018; 8(1):6801.
92. Hwang MH, Yoo JK, Luttrell M, Kim HK, Meade TH, English M, Segal
MS, Christou DD. Mineralocorticoid receptors modulate vascular endo-
thelial function in human obesity. Clin Sci (Lond). 2013; 125(11):513-
20.
93. Hwang MH, Yoo JK, Luttrell M, Meade TH, English M, Christou DD.
Effect of Selective Mineralocorticoid Receptor Blockade on Flow-Me-
diated Dilation and Insulin Resistance in Older Adults with Metabolic
Syndrome. Metab Syndr Relat Disord. 2015; 13(8):356-61.
94. Hwang MH, Yoo JK, Luttrell M, Kim HK, Meade TH, English M, Nichols
WW, Christou DD. Role of mineralocorticoid receptors in arterial stiffness
in human aging. Exp Gerontol 2013; 48(8):701-4.
95. Chen L, Ding ML, Wu F, He W, Li J, Zhang XY, Xie WL, Duan SZ, Xia
WH, Tao J. Impaired Endothelial Repair Capacity of Early Endothelial
Progenitor Cells in Hypertensive Patients With Primary Hyperaldoste-
ronemia: Role of 5,6,7,8-Tetrahydrobiopterin Oxidation and Endothelial
Nitric Oxide Synthase Uncoupling. Hypertension. 2016; 67(2):430-9.
96. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier
M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud
F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R,
Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder
RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Do-
cument Group. Collaborators (182). 2018 ESC/ESH Guidelines for the
management of arterial hypertension. Eur Heart J. 2018;
39(33):3021-3104.
97. Kolkhof P, Bärfacker L. 30 years of the mineralocorticoid receptor: Mi-
neralocorticoid receptor antagonists: 60 years of research and deve-
lopment. J Endocrinol. 2017; 234(1):T125-T140.
10. DECLARACIÓN DE TRANSPARENCIA
El autor/a de este artículo declara no tener ningún tipo de con-
flicto de intereses respecto a lo expuesto en la presente revisión.
Si desea citar nuestro artículo:
Briones y Rodrigues-Díez
Receptor mineralocorticoide extrarrenal. Una posible nueva diana para com-
batir el daño vascular.
An Real Acad Farm (Internet).
An Real Acad Farm Vol. 86. Nº 1 (2020) · pp. 61 -73
Receptor mineralocorticoide extrarrenal. Una posi-
ble nueva diana para combatir el daño vascular.
Ana M. Briones y Raquel Rodrigues-Díez
An Real Acad Farm Vol. 86. Nº 1 (2020) · pp. 61 -73
